MAZE
Maze Therapeutics, Inc.
26.40$
-0.8%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | -10.8% | +25.0% | +38.4% | -8.8% | +39.1% | -5.9% | +5.7% | +26.7% | |
| – | – | – | – | -14.2% | +31.0% | +48.6% | -9.5% | +44.3% | -10.6% | +8.6% | +10.7% | |
| – | – | – | – | -14.5% | +31.6% | +49.6% | -10.1% | +19.7% | -40.3% | +5.0% | +2.0% | |
| – | – | – | – | -14.5% | +31.6% | +49.6% | -10.1% | +45.1% | -10.9% | +3.1% | +16.7% | |
| – | – | – | – | – | – | – | – | – | +114.3% | +1,233.3% | -86.0% | |
| – | – | – | – | -80.5% | -53.1% | -6.6% | +1.2% | +3.2% | -1.1% | +85.0% | +0.6% | |
| – | – | – | – | -18.7% | +17.8% | -9.9% | +6.9% | +11.1% | +2.0% | -5.9% | +8.1% | |
| – | – | – | – | +1.0% | +0.3% | +0.9% | +0.9% | +1.0% | +0.7% | +0.9% | +0.9% | |
| – | – | – | – | -53.4% | +90.5% | +24.0% | +52.5% | -20.4% | -38.5% | +123.7% | -44.9% | |
| – | – | – | – | +5.4% | – | – | – | – | – | – | +0.3% | |
| – | – | – | – | – | +98.2% | +48.3% | -10.2% | +44.7% | -6.4% | -3.7% | +32.6% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | +0.0% | 0.0% | 0.0% | +0.0% | +0.0% | +0.1% | +4.4% | -6.1% | +25.4% | +9.5% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.